EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Present and future of liver transplantation for cholangiocellular carcinoma: moving toward personalized multiparametric transplantability patterns

Umberto Cillo, Alessandro Furlanetto, Jacopo Lanari, Eleonora Nieddu, Eugenia Rosso, Francesco Enrico D'Amico, Domenico Bassi, Enrico Gringeri

Transplant International · 07.05.2026 · 39

DOI: 10.3389/ti.2026.15786 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant International, online erschienen am 07.05.2026. Verfasst von Umberto Cillo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Liver Transplantation, Bile Duct Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver transplantation for cholangiocarcinoma (CCA) shifted from a contraindication to a promising therapeutic option for selected patients. Advances in neoadjuvant therapy and refined selection criteria resulted in long-term outcomes comparable to other accepted oncologic indications, particularly in perihilar CCA managed with standardized protocols and in intrahepatic CCA with favorable tumor biology. The future challenge is to develop a multiparametric biological selection, blending clinical, functional, histopathologic, molecular, and radiologic parameters to identify candidates with indolent disease behavior, thus maximizing oncologic benefit while ensuring appropriate use of limited graft resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaLiver TransplantationBile Duct NeoplasmsHumansPatient SelectionBile Ducts, IntrahepaticPrecision MedicineNeoadjuvant TherapyBiomarkers, Tumor

Stichwörter der Autor:innen

cholangiocarcinomaliver transplanttransplant assessmenttransplant oncologytumor biomarkers

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Padua, Italy.
  • Hepato-Bilio-Pancreatic Surgery and Liver Transplantation Unit, Azienda Ospedale Universita Padova, Padua, Italy.

Zitieren

APA

Cillo, U., Furlanetto, A., Lanari, J., Nieddu, E., Rosso, E., D'Amico, F. E., Bassi, D., & Gringeri, E. (2026). Present and future of liver transplantation for cholangiocellular carcinoma: moving toward personalized multiparametric transplantability patterns. Transplant International, 39. https://doi.org/10.3389/ti.2026.15786

Vancouver

Cillo U, Furlanetto A, Lanari J, Nieddu E, Rosso E, D'Amico FE, et al. Present and future of liver transplantation for cholangiocellular carcinoma: moving toward personalized multiparametric transplantability patterns. Transplant International. 2026;39. doi:10.3389/ti.2026.15786

BibTeX
@article{Cillo2026,
  author = {Cillo, Umberto and Furlanetto, Alessandro and Lanari, Jacopo and Nieddu, Eleonora and Rosso, Eugenia and D'Amico, Francesco Enrico and Bassi, Domenico and Gringeri, Enrico},
  title = {Present and future of liver transplantation for cholangiocellular carcinoma: moving toward personalized multiparametric transplantability patterns},
  journal = {Transplant International},
  year = {2026},
  volume = {39},
  doi = {10.3389/ti.2026.15786}
}
Kostenlos starten →